Michael Grabner

12PUBLICATIONS
31CO-AUTHORS
Pharmaceutical delivery technologiesPharmacogenomicsEpidemiological modellingTraditional Chinese medicine and treatmentsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Aug 10, 2026
Tirzepatide Persistence and Associated Changes in Clinical Outcomes in US Adults With Obesity or Overweight: A 6-Month Claims Database Analysis.

|Feb 25, 2026
Characteristics and Utilization Patterns of Medicare Beneficiaries Initiating Long-Acting Injectable Antipsychotic Medications.

Michael Grabner, Yueh-Yi Chiang, Chia-Chen Teng

|Apr 04, 2025
Association of tirzepatide with glycaemic control and weight loss in a real world cohort of patients with type 2 diabetes from the United States.

Reema Mody, Karishma Desai, Chia-Chen Teng

|Dec 14, 2021
Comparative Effectiveness of Persistent Use of a Name-Brand Levothyroxine (Synthroid®) vs. Persistent Use of Generic Levothyroxine on TSH Goal Achievement: A Retrospective Study Among Patients with Hypothyroidism in a Managed Care Setting.

Liya Wang, Yaozhu J Chen, Michael Grabner

|Nov 12, 2021
Treatment Experiences with CDK4&6 Inhibitors Among Women with Metastatic Breast Cancer: A Qualitative Study.

Judith J Stephenson, Jonathon Colby Gable, Rebekah Zincavage

|Sep 22, 2021
Cost-Effectiveness of a Proteomic Test for Preterm Birth Prediction.

Michael Grabner, Julja Burchard, Chi Nguyen

Pageof 2

Frequent Collaborators

2 joint publications

Michael J Fisch

2 joint publications

Gebra Cuyun Carter

2 joint publications

Lee Bowman

2 joint publications

Karishma Desai